156 related articles for article (PubMed ID: 18714317)
1. The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics.
Lesko LJ
Clin Pharmacol Ther; 2008 Sep; 84(3):301-3. PubMed ID: 18714317
[No Abstract] [Full Text] [Related]
2. Overview of pharmacogenetics in anticoagulation therapy.
Hill CE; Duncan A
Clin Lab Med; 2008 Dec; 28(4):513-24. PubMed ID: 19059059
[TBL] [Abstract][Full Text] [Related]
3. Warfarin sensitivity and genetic polymorphisms: should pharmacokinetic screening be part of anticoagulant dosing decisions?
Baglin TP
Clin Adv Hematol Oncol; 2003 Nov; 1(11):656-7. PubMed ID: 16258463
[No Abstract] [Full Text] [Related]
4. Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? Yes.
Thacker SM; Grice GR; Milligan PE; Gage BF
J Thromb Haemost; 2008 Sep; 6(9):1445-9. PubMed ID: 18627440
[No Abstract] [Full Text] [Related]
5. Warfarin and pharmacogenomic testing: the case for restraint.
Garcia DA
Clin Pharmacol Ther; 2008 Sep; 84(3):303-5. PubMed ID: 18714318
[No Abstract] [Full Text] [Related]
6. Pharmacogenomics and the management of oral anticoagulation.
Wittkowsky AK
Curr Hematol Rep; 2004 Sep; 3(5):363-7. PubMed ID: 15341704
[TBL] [Abstract][Full Text] [Related]
7. Avoiding overanticoagulation: pharmacogenomics or pragmatism?
Baglin T
Thromb Haemost; 2001 May; 85(5):945-6. PubMed ID: 11372698
[No Abstract] [Full Text] [Related]
8. [Pharmacogenetics in practice].
Spigset O
Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1679. PubMed ID: 18720559
[No Abstract] [Full Text] [Related]
9. Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin.
George J; Doney A; Palmer CN; Lang CC
Cardiovasc Ther; 2010 Jun; 28(3):135-8. PubMed ID: 20557312
[No Abstract] [Full Text] [Related]
10. CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences.
Takahashi H; Wilkinson GR; Padrini R; Echizen H
Clin Pharmacol Ther; 2004 May; 75(5):376-80. PubMed ID: 15116049
[No Abstract] [Full Text] [Related]
11. Predicting warfarin dose.
Lazo-Langner A; Kovacs MJ
Curr Opin Pulm Med; 2010 Sep; 16(5):426-31. PubMed ID: 20473166
[TBL] [Abstract][Full Text] [Related]
12. Warfarin: an old drug but still interesting.
Johnson JA
Pharmacotherapy; 2008 Sep; 28(9):1081-3. PubMed ID: 18752378
[No Abstract] [Full Text] [Related]
13. Clinical applications of pharmacogenomics guided warfarin dosing.
Mahajan P; Meyer KS; Wall GC; Price HJ
Int J Clin Pharm; 2013 Jun; 35(3):359-68. PubMed ID: 21052837
[TBL] [Abstract][Full Text] [Related]
14. A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) in a patient on warfarin therapy.
Herman D; Peternel P; Stegnar M; Breskvar K; Dolzan V
Thromb Haemost; 2006 Jan; 95(1):192-4. PubMed ID: 16543980
[No Abstract] [Full Text] [Related]
15. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
Owen RP; Altman RB; Klein TE
Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
[TBL] [Abstract][Full Text] [Related]
16. [A 60-year-old man with heart failure, dry cough and elevated INR values].
Kamal Z; Nordstad MG; Molden E
Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1677-9. PubMed ID: 18720558
[No Abstract] [Full Text] [Related]
17. Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin.
Takahashi H; Echizen H
Pharmacogenomics J; 2003; 3(4):202-14. PubMed ID: 12931134
[No Abstract] [Full Text] [Related]
18. Individual genomes instead of race for personalized medicine.
Ng PC; Zhao Q; Levy S; Strausberg RL; Venter JC
Clin Pharmacol Ther; 2008 Sep; 84(3):306-9. PubMed ID: 18714319
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
Leey JA; McCabe S; Koch JA; Miles TP
Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
[TBL] [Abstract][Full Text] [Related]
20. Clinical applications of pharmacogenomics guided warfarin dosing.
Mahajan P; Meyer KS; Wall GC; Price HJ
Int J Clin Pharm; 2011 Feb; 33(1):10-9. PubMed ID: 21365388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
